Literature DB >> 15126526

Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study.

F Monzani1, N Caraccio, M Kozàkowà, A Dardano, F Vittone, A Virdis, S Taddei, C Palombo, E Ferrannini.   

Abstract

Subclinical hypothyroidism (sHT) is associated with dyslipidemia and enhanced cardiovascular risk. We assessed carotid artery intima-media thickness (IMT, high-resolution ultrasonography) and lipoprotein profile in 45 sHT patients (aged 37 +/- 11 yr) at baseline and after 6 months of randomized, placebo-controlled L-T(4) replacement. In comparison with 32 age- and sex-matched controls, sHT patients had elevated total and low-density lipoprotein (LDL) cholesterol and ApoB levels (P = 0.002, P = 0.0007, and P = 0.01, respectively) and higher mean-IMT values (P < 0.0001). In stepwise regression analysis, mean-IMT was positively related (r(2) = 0.71, P < 0.0001) to age, TSH, and LDL cholesterol. L-T(4) replacement significantly reduced both total and LDL cholesterol (P < 0.0001 for both) and mean-IMT (by 11%, P < 0.0001). The decrement in IMT was directly related to the decrements of both total cholesterol and TSH (P = 0.02 and P = 0.0001, respectively). We conclude that early carotid artery wall alterations are present in sHT patients. Whether such IMT increase is related to an early atherosclerotic involvement of the arterial wall cannot be clearly decided on the basis of the present results. However, the fact that L-T(4) replacement therapy was able to improve both the atherogenic lipoprotein profile and intima-media thickening suggests that lipid infiltration of arterial wall may represent a major mechanism underlying IMT increase in subclinical hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126526     DOI: 10.1210/jc.2003-031669

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  84 in total

Review 1.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

2.  High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease.

Authors:  A C Hauser; A Gessl; M Lorenz; T Voigtländer; M Födinger; G Sunder-Plassmann
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 3.  The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence.

Authors:  E Galli; A Pingitore; G Iervasi
Journal:  Heart Fail Rev       Date:  2008-12-27       Impact factor: 4.214

4.  Thyrotropin blood levels, subclinical hypothyroidism, and the elderly patient.

Authors:  Joanna Klubo-Gwiezdzinska; Leonard Wartofsky
Journal:  Arch Intern Med       Date:  2009-11-23

5.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

Review 6.  Hypothyroidism and dyslipidemia: modern concepts and approaches.

Authors:  Elizabeth N Pearce
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

7.  Relation of Low T3 to One-Year Mortality in Non-ST-Elevation Acute Coronary Syndrome Patients.

Authors:  Selçuk Yazıcı; Tuncay Kırış; Ufuk S Ceylan; Sait Terzi; Aysun Erdem; Işıl Atasoy; Ayşe Emre; Kemal Yeşilçimen
Journal:  J Clin Lab Anal       Date:  2016-08-27       Impact factor: 2.352

8.  No evidence of association between subclinical thyroid disorders and common carotid intima medial thickness or atherosclerotic plaque.

Authors:  A P Delitala; F Filigheddu; M Orrù; M AlGhatrif; M Steri; M G Pilia; A Scuteri; M Lobina; M G Piras; G Delitala; E G Lakatta; D Schlessinger; F Cucca
Journal:  Nutr Metab Cardiovasc Dis       Date:  2015-10-21       Impact factor: 4.222

9.  Endothelial function is not changed during short-term withdrawal of thyroxine in patients with differentiated thyroid cancer and low cardiovascular risk.

Authors:  Hyuk-Jae Chang; Kyung Won Kim; Sung Hee Choi; Soo Lim; Kyoung Un Park; Do Joon Park; Dong Joo Choi; Hak C Jang; Bo Youn Cho; Young Joo Park
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

10.  Increased carotid IMT in overweight and obese women affected by Hashimoto's thyroiditis: an adiposity and autoimmune linkage?

Authors:  Marco M Ciccone; Giovanni De Pergola; Maria T Porcelli; Pietro Scicchitano; Pasquale Caldarola; Massimo Iacoviello; Guida Pietro; Francesco Giorgino; Stefano Favale
Journal:  BMC Cardiovasc Disord       Date:  2010-05-28       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.